graft

(redirected from delayed graft)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial.

graft,

in surgery: see transplantation, medicaltransplantation, medical,
surgical procedure by which a tissue or organ is removed and replaced by a corresponding part, usually from another part of the body or from another individual.
..... Click the link for more information.
.

graft

[graft]
(biology)
To unite to form a graft.
A piece of tissue transplanted from one individual to another or to a different place on the same individual.
An individual resulting from the grafting of parts.
(botany)
To unite a scion to an understock in such manner that the two grow together and continue development as a single plant without change in scion or stock.

graft

To join a scion, shoot, or bud to the stock of another similar plant.

graft

1. Horticulture
a. a piece of plant tissue (the scion), normally a stem, that is made to unite with an established plant (the stock), which supports and nourishes it
b. the plant resulting from the union of scion and stock
c. the point of union between the scion and the stock
2. Surgery a piece of tissue or an organ transplanted from a donor or from the patient's own body to an area of the body in need of the tissue
References in periodicals archive ?
According to the study's authors, there is an unmet medical need for an effective test to help predict delayed graft function soon after transplantation, which could help in developing therapeutic interventions to prevent DGF.
Machine perfusion significantly reduced the risk of delayed graft function compared to cold storage.
the timing and results of anticipated events in our clinical development programs including studies with Cinryze subcutaneous formulation, Cinryze for antibody mediated rejection and delayed graft function, as well as VP20621 for recurrence of C.
The impact of delayed graft function on the long-term outcome of renal transplantation.
DGFi is being investigated for the prevention and treatment of Delayed Graft Function ("DGF") associated with renal transplantation.
Based on Silence's AtuRNAi technology, Quark is developing its QPI-1002 for the prevention of acute kidney injury (AKI) in patients undergoing major cardiovascular surgery, and for the prophylaxis of delayed graft function (DGF) in patients receiving deceased donor kidney transplants.
CTI Clinical Trial and Consulting Services (CTI), Cincinnati, OH, announced it will initiate a Phase II clinical program of YSPSL for the prevention of delayed graft function (DGF) in patients undergoing deceased donor kidney transplantation.
a privately held biopharmaceutical company, announced the initiation of a Phase II clinical program of YSPSL for prevention of delayed graft function (DGF) in patients undergoing cadaveric kidney transplantation.
Simulect (Novartis) trial for induction; an NIH-sponsored Delayed Graft Function trial; a trial for the treatment of Myelodysplastic Syndrome (MDS); and other clinical trials.
Tokyo, Japan, a privately held biopharmaceutical company, has initiated a Phase II clinical trial for YSPSL for the prevention of delayed graft function (DGF) in patients undergoing cadaveric kidney transplantation.
NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure, is in development for the prevention of delayed graft function (DGF) in kidney transplantation patients.
Folkert Belzer and Geoffrey Collins using evidence-based medicine that is highly relevant given the increasing use of older and more marginal donor organs that are more susceptible to delayed graft function or nonfunction," said Professor Rutger Ploeg, coordinating principal investigator of the trial at the University Medical Center Groningen, Netherlands.

Full browser ?